Pharmaceutical Research

, Volume 28, Issue 2, pp 237–259

Inorganic Nanoparticles in Cancer Therapy

Authors

  • Sanjib Bhattacharyya
    • Department of Biochemistry and Molecular Biology College of MedicineMayo Clinic
  • Rachel A. Kudgus
    • Department of Biochemistry and Molecular Biology College of MedicineMayo Clinic
  • Resham Bhattacharya
    • Department of Biochemistry and Molecular Biology College of MedicineMayo Clinic
    • Department of Biochemistry and Molecular Biology College of MedicineMayo Clinic
    • Department of Biochemistry and Molecular Biology Department of Biomedical Engineering Mayo Clinic Cancer Center College of MedicineMayo Clinic
Expert Review

DOI: 10.1007/s11095-010-0318-0

Cite this article as:
Bhattacharyya, S., Kudgus, R.A., Bhattacharya, R. et al. Pharm Res (2011) 28: 237. doi:10.1007/s11095-010-0318-0

ABSTRACT

Nanotechnology is an evolving field with enormous potential for biomedical applications. The growing interest to use inorganic nanoparticles in medicine is due to the unique size- and shape-dependent optoelectronic properties. Herein, we will focus on gold, silver and platinum nanoparticles, discussing recent developments for therapeutic applications with regard to cancer in terms of nanoparticles being used as a delivery vehicle as well as therapeutic agents. We will also discuss some of the key challenges to be addressed in future studies.

KEY WORDS

cancerdrug deliverygoldinorganicnanoparticletherapeutics

Copyright information

© Springer Science+Business Media, LLC 2010